GABRIELLE KAYTON: Open Payments
NPI 1184262677 · DAVIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 73 payments from 8 companies in 2025. Trend: 2023 $1,059 · 2024 $193 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 62 | $552 |
| Ferring Pharmaceuticals Inc. | 2 | $143 |
| Teleflex LLC | 2 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Boston Scientific Corporation | 2 | $33 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $19 |
| TOLMAR, INC. | 1 | $19 |
Products named: ADSTILADRIN, SpeediCath, BARRIGEL, AMS 700, ORGOVYX, PYLARIFY, RYBREVANT, JATENZO.
Industry payments across FL — which companies pay providers there.
